Q1 FY2027 · ended Jul 31, 2026 · Revenue $321,576, +209.5% YoY · Filed Sep 14, 2026
VitaNova Life Sciences Corporation (VNOV) files with the SEC under industry code 5130, Wholesale-Apparel, Piece Goods & Notions. In Q1 of fiscal 2027, the quarter ended Jul 31, 2026, it reported revenue of $321,576 and a net loss of $123,101.
Revenue
$321,576
+209.5% vs year-ago quarter
Net income
$-123,101
-165.9% vs year-ago quarter
Operating cash flow
$6,965
-97.4% vs year-ago quarter
Free cash flow
—
EPS
$-0.01
-200.0% vs year-ago quarter
Dividend per share
None
Shares outstanding
8.34M
-66.7% vs year-ago quarter
Net cash
—
Operating margin
-2.7%
TTM
Company profile
- Industry
- Wholesale-Apparel, Piece Goods & Notions (SIC 5130)
- Listed as
- VNOV (OTC)
- Fiscal year ends
- April 30
- Incorporated in
- NV
- Headquarters
- New York, NY
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1699709
- Former names
- YIJIA GROUP CORP. (until Jan 13, 2026); YIJIA GROUP CORP (until Jul 29, 2019); Soldino Group Corp (until Nov 26, 2018)
Other Wholesale-Apparel, Piece Goods & Notions companies
- Weyco Group Inc WEYS
- Stark Focus Group, Inc. SKFG
- Authentic Holdings, Inc. AHRO
- KEEMO Fashion Group Ltd KMFG
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q1 FY2027 Jul 31, 2026 |
Q4 FY2026 Apr 30, 2026 |
Q3 FY2026 Jan 31, 2026 |
Q2 FY2026 Oct 31, 2025 |
Q1 FY2026 Jul 31, 2025 |
|---|---|---|---|---|---|
| Revenue | $321,576 | $1.8M | $709,625 | $427,115 | $103,899 |
| Operating income | -$122,162 | -$109,860 | $46,731 | $99,170 | -$32,440 |
| Net income | -$123,101 | $17,549 | -$44,362 | $35,810 | -$46,301 |
| Diluted EPS | — | — | -$0.01 | $0.00 | $0.00 |
| Operating cash flow | $6,965 | $428,313 | -$90,377 | $212,660 | $263,811 |
| Total assets | $2.2M | $2.4M | $2.3M | $2.3M | $2.2M |
| Total liabilities | $311,656 | $395,781 | $457,975 | $438,051 | $379,975 |
| Stockholders' equity | $1.9M | $2.1M | $1.9M | $1.9M | $1.9M |
| Cash and investments | $1.6M | $1.6M | $1.2M | $1.3M | $1.0M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Sep 14, 2026 | Jul 31, 2026 |
| 10-K | Annual report | Jul 29, 2026 | Apr 30, 2026 |
| 8-K |
Current report
Officer or director change
|
Mar 18, 2026 | Mar 12, 2026 |
| 10-Q | Quarterly report | Mar 16, 2026 | Jan 31, 2026 |
| 8-K |
Current report
Officer or director change
|
Feb 25, 2026 | Feb 19, 2026 |
| 8-K |
Current report
Other events
|
Jan 27, 2026 | Jan 27, 2026 |
All 97 VitaNova Life Sciences Corporation SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.